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Abstract
Background: The Friedewald formula (FF) is useful for calculating serum low-density lipoprotein cholesterol (LDL-C) 
values, but has a remarkable deviation and limitation especially in hypertriglyceridemia. We modify the formula which 
is now more suitable for LDL-C calculation.
Methods: 2180 cases were classified into three groups according to their TG concentrations (A: < 200 mg/dl, n = 1220; 
B: 200-400 mg/dl, n = 480; C: 400-1000 mg/dl, n = 480). The concentrations of LDL-C were measured or estimated by 1) 
a direct measurement (DM); 2) the FF; and 3) our modified Friedewald formula (MFF): LDL-C (mg/dl) = Non-HDL-C × 
90% - TG × 10%.
Results: Linear regression showed a significant correlation (P < 0.001) between the measured and calculated LDL-C 
values. Bland-Altman plots indicated that the methods (DM/MFF) were in better agreement than those (DM/FF). The 
LDL-C/Non-HDL-C ratio in FF calculated values was significantly lower (P < 0.05) than that in MFF or DM values, while 
no significant difference between MFF and DM was found. In Group A and Group B, 4.26% and 14.79% of the MFF 
calculated values had more than 20% deviation from those measured by DM. These percentages were significantly 
lower than those calculated by FF, where 7.30% and 25.63% were observed, respectively (P < 0.01 and P < 0.001). The 
MFF calculated values were all positive even in Group C.
Conclusions: Compared with the FF calculation, serum LDL-C values estimated by our modified formula are closer to 
those measured by a direct assay. The modification significantly diminishes the interference caused by 
hypertriglyceridemia.
Introduction
Serum low-density lipoprotein cholesterol (LDL-C) is an
independent risk factor for the development of coronary
heart disease [1]. The National Cholesterol Education
Program Adult Treatment Panel and other scientific soci-
eties have identified LDL-C concentrations as the pri-
mary criterion of diagnosis and treatment of patients
with hyperlipidemia [2,3].
Most clinical laboratories estimated LDL-C concentra-
tions in serum by the Friedewald formula (FF) from the
concentrations of total cholesterol (TC), triglyceride
(TG), and high-density lipoprotein cholesterol (HDL-C)
[4-6]. The traditional FF is: LDL-C (mg/dl) = Non-HDL-
C - TG/5. TG is mainly from chylomicrons and VLDL.
Assuming Non-HDL-C has little or no change, if TG lev-
els are too high, the LDL-C values would be underesti-
mated. This could occur in the postprandial condition or
patient with normal Non-HDL-C but high TG levels. The
FF estimated value is not valid in specimens with TG
more than 400 mg/dl [7,8]. Indeed, it has been recom-
mended that the FF should be used with precaution in
several pathologic states (diabetes, hepatopathy, neph-
ropathy), even if the TG concentrations are between 200
mg/dl and 400 mg/dl [9,10]. In previous reports, the for-
mula was modified to overcome the limitation [11-15].
However, these modifications were either complicated or
lacking rationales. From the FF, we can see LDL-C is
determined by the correlated parameters of none high-
density lipoprotein cholesterol (Non-HDL-C) and TG.
We may reach to a suitable point through adjusting both
parameters. We proposed a modified Friedewald formula
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(MFF). Based on the formula, we calculated LDL-C val-
ues which were compare with the FF and a direct homo-
geneous assay.
Materials and methods
Blood samples were obtained from 2180 adult outpa-
tients, ages >18 years, at the department of clinical labo-
ratory of Zhongshan Hospital. Blood was collected in
tubes without anticoagulant from subjects after an over-
night fast. The samples were allowed to clot at room tem-
perature, and serum was obtained by centrifugation at
3000 rpm for 15 minutes. All blood lipid analyses were
performed within 1 day. All subjects were classified into
three groups according to the TG concentrations (A: <
200 mg/dl, n = 1220; B: 200-400 mg/dl, n = 480; C: 400-
1000 mg/dl, n = 480). The Non-HDL-C concentrations in
all samples were less than 300 mg/dl. To convert values
for TG and cholesterol to millimoles per liter, we multiply
the values with 0.0113 and 0.0259, respectively.
The Non-HDL-C value was estimated by the formula as
follows [16]:
Lipid measurements were performed on a Hitachi 911
automatic analyzer. The LDL-C assay was performed
according to Roche manufacture's specifications. At the
same time, the LDL-C values were also calculated by the
FF and MFF. TC and TG concentrations were determined
enzymatically using CHOD-PAP and lipase/GPO/PAP
methods, respectively. The HDL-C concentration was
measured by phosphotungstic acid and MgCl2 precipita-
tion approach. The reagents were obtained from Roche
Diagnostics. The procedures and efficiency of lipid assays
had been demonstrated previously [17]. The total error
used in precision assessment was 3.95%-7.85% for the
Roche method, as recommended by the National Choles-
terol Education Program.
The FF was transformed as follows:
Multivariate linear regression analysis was used to
investigate the relationship between LDL-C (expected
value), TG and Non-HDL-C (explanatory variables) con-
centrations. Repeatability of the new formula was evalu-
ated by Bland-Altman analysis [18]:. We compared the
agreement between FF and our new formula, and calcu-
lated the mean and standard deviation of the differences
(formula and lab value). The mean difference of both FF
and new formula were close to zero. We concluded the
MFF as follows:
Statistical analysis was performed using SPSS 11.5 for
Windows (SPSS Inc., USA). Linear regression analyses
were used to assess the correlations between the methods
Non HDL C TC HDL C −− = −−
LDL C mg dl Non HDL C TG −= − − − × (/ ) % 20
LDL C mg dl Non HDL C −= − − × − × (/ ) % % 90 10 TG
Figure 1 Correlations for LDL-C in subjects with different TG values. The LDL-C values were significantly correlated between the MFF and DM (P 
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of formula calculation and direct measurement. To exam-
ine the degree of consistency between values obtained by
the two methods, we used the graphical procedure out-
lined by Bland and Altman. Comparisons between groups
were performed using the method of ANOVA. The test of
Pearson chi-square was used to compare discrete vari-
ables. P values less than 0.05 were considered significant.
Results
As shown in the Figure 1, the LDL-C values were signifi-
cantly correlated between the MFF and DM (P < 0.001).
In the group with TG >400 mg/dl, our formula but not
traditional FF fit well with the DM. As shown in the Fig-
ure 2, the difference between the DM and the formula
methods for LDL-C, depending on the TG values, was
plotted against the average of the methods. The Bland-
Altman plots indicated a good agreement between the
methods of DM and MFF. As shown in the Figure 3, the
ratios of LDL-C to Non-HDL-C values were significantly
decreased in the subjects with hypertriglyceridemia. This
ratio in FF calculated values was significantly lower (P <
0.05) than that in MFF or DM values, even in Group B
(TG: 200-400 mg/dl), while no significant difference
between the MFF and DM was found.
In order to evaluate MFF is better than FF, we also cal-
culated LDL-C values using MFF and FF in Group A (TG
< 200 mg/dl) and Group B (TG: 200-400 mg/dl) and then
compared these values with that measured by DM. We
found that 4.26% and 14.79% of the values calculated by
the MFF had more than 20% deviation form that mea-
sured by DM. These percentages were significantly lower
than those calculated by FF, where 7.30% and 25.63%
were observed, respectively (X2 = 10.305, P < 0.01 and X2
= 17.468, P < 0.001), suggesting MFF works better than
FF in predicting LDL-C values at least in these popula-
tions. We compared LDL-C values measured by MFF or
FF with those measured by DM. We found that all MFF
calculated values were positive ones, while 10.42% of FF
calculated values were negative. The results indicated our
modified formula could provide a better estimate of LDL-
C values than FF.
Discussion
The LDL-C value is estimated using the FF, which can be
transformed as follows: LDL-C (mg/dl) = Non-HDL-C -
Figure 2 Bland-Altman plots for LDL-C in subjects with different TG values. In the Bland-Altman plots the difference between the direct method 
(DM) and the formula method for LDL-C, depending on serum TG values, was plotted against the average of the methodsChen et al. Lipids in Health and Disease 2010, 9:52
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TG × 20%. In the formula, the concentration of very low-
density lipoproteins (VLDL) is estimated as 20% of total
TG concentrations [4]. However, the particles found in
patients with hypertriglyceridemia are usually a heteroge-
neous mixture of chylomicron remnants, VLDL, and
VLDL remnants [19]. It is well known that the ratio of TG
to cholesterol (TG/cholesterol) varies a lot within these
particles. When the TG concentration is more than 400
mg/dl, the cholesterol in TG-rich lipoproteins is overesti-
mated by the FF method, resulting that the calculated
LDL-C value even appears negative [20]. Therefore, this
method has a limitation in clinical application.
In this study, the FF estimated value was calibrated
using different coefficients to avoid LDL-C underestima-
tion. We examined the correlation between traditional FF
and our new formula, and found that both of FF and MFF
fit well with the DM in the subjects with TG < 400 mg/dl.
While If the TG concentrations were higher than 400 mg/
dl, our formula but not traditional FF fit well with the
DM. However, because high coefficients do not necessar-
ily mean that two methods agree. We assessed the degree
of agreement between the two methods using the Bland-
Altman graphical technique. The Bland-Altman graphs
are plots of the difference between the two methods
against their mean. The degree of agreement is indicated
by calculating the bias, estimated by the mean and SD of
the differences. The figure 2 showed an obvious relation-
ship between the differences and the mean. The Bland-
Altman plots suggest that the methods (DM/MFF) are in
better agreement than those (DM/FF). Moreover, The
MFF calculated values had a smaller deviation from the
DM values and a regular relationship with the Non-HDL-
C values, showing our new formula works better than
classical FF.
In summary, a modified formula for LDL-C calculation
was designed in this study: LDL-C (mg/dl) = Non-HDL-C
× 90% - TG × 10%. The MFF estimated LDL-C values
have following characteristics: 1). They are closer to those
measured by the DM than those estimated by the FF; 2).
They have a stable LDL-C/Non-HDL-C ratio; and 3). The
interference caused by hypertriglyceridemia might be sig-
nificantly diminished. Therefore, the MFF has higher
accuracy than FF. Although our findings need to be con-
firmed in additional studies, they hold a promise of
broadening the usage of the FF in LDL-C measurement.
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